In addition, the Wilcoxon rank-sum test demonstrated that high-risk score groups have a higher level of immune cells in the tumor microenvironment, such as B cells memory, T cells CD4 memory resting and mast cells activated (Figure 8C). The gene discussed is CD4; the disease is neoplasm.